Further research is needed to identify and manage possible side effects, such as the effects on gastric emptying and the need for safety precautions during anesthesia
"For many people with type 2 diabetes, it is a struggle to achieve both A1C control and weight loss, since obesity has historically been harder to treat for those with type 2 diabetes," said TRANSCEND-T2D-1 Efficacy Results Retatrutide also showed clinically meaningful improvements from baseline across key cardiovascular risk factors, including non-HDL cholesterol, triglycerides and systolic blood pressure
We will look at your anatomy, the operation you are considering, your overall health, and we will decide together whether peptides belong in your protocol
However, like all medications, it does carry some risks and isn't right for everyone
Market data on US launch performance is sourced from Novo Nordisk Q1 2026 and Eli Lilly Q1 2026 investor presentations